Atlas FDA

MATRIX VASCULAR CLOSURE SYSTEM (VSG)

FDA premarket approval P040044 · decided 2005-08-17

Approval details

PMA number
P040044
Trade name
MATRIX VASCULAR CLOSURE SYSTEM (VSG)
Generic name
Device, hemostasis, vascular
Applicant
Cordis US Corporation
Date received
2004-11-04
Decision date
2005-08-17
Days to decision
286 days
Decision code
APPR
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Miami Lakes, FL
Statement
APPROVAL FOR THE MATRIX VSG SYSTEM, MODEL MX-100. THE DEVICE IS INDICATED FOR USE TO SEAL FEMORAL ARTERIAL ACCESS SITES WHILE REDUCING TIMES TO HEMOSTASIS AND AMBULATION IN PATIENTS WHO HAVE UNDERGONE DIAGNOSTIC OR INTERVENTIONAL ENDOVASCULAR PROCEDURES UTILIZING A 5F, 6F, OR 7F PROCEDURAL SHEATH.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.